1887

Abstract

Diagnostic, genotypic and antibiotic-resistance determinants of were analysed by molecular methods to verify the failure of ceftriaxone treatment in two cases of pharyngeal gonorrhoea. Monoplex assays were needed to define competitive inhibition of a positive PCR in a duplex assay. Different changes were detected in the isolated from the two cases. These were associated with raised ceftriaxone MICs of 0.03 and 0.016 mg l, which may have contributed to the treatment failures in these cases.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.007641-0
2009-05-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/58/5/683.html?itemId=/content/journal/jmm/10.1099/jmm.0.007641-0&mimeType=html&fmt=ahah

References

  1. Deguchi T., Yasuda M., Yokoi S., Ishida K.-I., Ito M., Ishihara S., Minamidate K., Harada Y., Tei K. other authors 2003; Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at 6-h interval. J Infect Chemother 9:35–39 [CrossRef]
    [Google Scholar]
  2. Goire N., Nissen M. D., LeCornec G. M., Sloots T. P., Whiley D. M. 2008; A duplex Neisseria gonorrhoeae real-time polymerase chain reaction assay targeting the gonococcal porA pseudogene and multicopy opa genes. Diagn Microbiol Infect Dis 61:6–12 [CrossRef]
    [Google Scholar]
  3. Ito M., Deguchi T., Mizutani K.-S., Yasuda M., Yokoi S., Ito S.-I., Takahashi Y., Ishihara S., Kawamura Y., Ezaki T. 2005; Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan. Antimicrob Agents Chemother 49:137–143 [CrossRef]
    [Google Scholar]
  4. Lo J. Y. C., Ho K. M., Leung A. O. C., Tiu F. S. T., Tsang G. K. L., Lo A. C. T., Tapsall J. W. 2008; Ceftibuten resistance and treatment failure in Neisseria gonorrhoeae infection. Antimicrob Agents Chemother 52:3564–3567 [CrossRef]
    [Google Scholar]
  5. Lynagh Y., Crowley B., Walsh A. 2007; An investigation to determine if newly-discovered variant of Chlamydia trachomatis is present in Ireland. Euro Surveill 12:E070201–2
    [Google Scholar]
  6. Martin I. M. C., Ison C. A., Aanensen D. M., Fenton K. A., Spratt B. G. 2004; Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis 189:1497–1505 [CrossRef]
    [Google Scholar]
  7. Muratani T., Akasaka S., Kobayashi T., Yamada Y., Inatomi H., Takahashi K., Matsumoto T. 2001; Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan. Antimicrob Agents Chemother 45:3603–3606 [CrossRef]
    [Google Scholar]
  8. Muratani T., Inatomi H., Ando Y., Kawai S., Akasaka S., Matsumoto T. 2008; Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae . Int J Urol 15:837–842 [CrossRef]
    [Google Scholar]
  9. Osaka K., Takahura T., Narukawa K., Takahata M., Endo K., Kiyota H., Onodera S. 2008; Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone. J Infect Chemother 14:195–203 [CrossRef]
    [Google Scholar]
  10. Ripa T., Nilsson P. 2006; A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use in PCR diagnostic tests. Euro Surveill 11:E061109–2
    [Google Scholar]
  11. Sathia L., Ellis B., Phillip S., Winston A., Smith A. 2007; Pharyngeal gonorrhoea – is dual treatment the way forward?. Int J STD AIDS 18:647–648 [CrossRef]
    [Google Scholar]
  12. Simmons G., Jones N., Calder L. 2000; Equivalence of ceftriaxone and rifampicin in eliminating nasopharyngeal carriage of serogroup B Neisseria meningitidis . J Antimicrob Chemother 45:909–911 [CrossRef]
    [Google Scholar]
  13. Tapsall J. W., Phillips E. A. 1995; The sensitivity of 173 Sydney isolates of Neisseria gonorrhoeae to cefpodoxime and other antibiotics used to treat gonorrhoea. Pathology 27:64–66 [CrossRef]
    [Google Scholar]
  14. Whiley D. M., Buda P. J., Bayliss J., Cover J., Bates J., Sloots T. P. 2004; A new confirmatory Neisseria gonorrhoeae real-time PCR assay targeting the porA pseudogene. Eur J Clin Microbiol Infect Dis 23:705–710
    [Google Scholar]
  15. Whiley D., Bates J., Limnios A., Nissen M., Tapsall J., Sloots T. 2007a; Use of a novel screening PCR indicates presence of Neisseria gonorrhoeae isolates with a mosaic penA gene sequence in Australia. Pathology 39:445–446 [CrossRef]
    [Google Scholar]
  16. Whiley D. M., Limnios E. A., Ray S., Sloots T. P., Tapsall J. W. 2007b; Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob Agents Chemother 51:3111–3116 [CrossRef]
    [Google Scholar]
  17. Whiley D. M., Garland S. M., Harnett G., Lum G., Smith D. W., Tabrizi S. N., Sloots T. P., Tapsall J. W. 2008; Exploring “best practice” for nucleic acid detection of Neisseria gonorrhoeae . Sex Health 5:17–23 [CrossRef]
    [Google Scholar]
  18. Workowski K. A., Berman S. M., Douglas J. M. Jr 2008; Emerging antimicrobial resistance in Neisseria gonorrhoeae : urgent need to strengthen prevention strategies. Ann Intern Med 148:606–613 [CrossRef]
    [Google Scholar]
  19. Yokoi S., Takashi Deguchi T., Ozawa T., Yasuda M., Ito S.-I., Kubota Y., Tamaki M., Maeda S.-I. 2007; Threat to cefixime treatment for gonorrhea. Emerg Infect Dis 13:1275–1277
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.007641-0
Loading
/content/journal/jmm/10.1099/jmm.0.007641-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error